IceCure Medical Ltd. Files 2024 Annual Report

Ticker: ICCM · Form: 20-F · Filed: Mar 27, 2025 · CIK: 1584371

Sentiment: neutral

Topics: annual-report, 20-f, medical-devices

TL;DR

IceCure Medical filed its 2024 20-F, check it for the latest on their medical tech biz.

AI Summary

IceCure Medical Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in Israel, is involved in the surgical and medical instruments and apparatus industry. The report was filed on March 27, 2025, and provides information on the company's operations and financial status.

Why It Matters

This filing provides investors and the public with a comprehensive overview of IceCure Medical Ltd.'s performance and financial health for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.

Risk Assessment

Risk Level: medium — As a medical device company, IceCure Medical faces inherent risks related to regulatory approvals, market adoption, and competition, which are typical for the industry.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of IceCure Medical Ltd.?

IceCure Medical Ltd. is involved in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

When did IceCure Medical Ltd. file its annual report?

The company filed its annual report on Form 20-F on March 27, 2025.

What fiscal year does this 20-F report cover?

This 20-F report covers the fiscal year ended December 31, 2024.

Who is the Chief Executive Officer of IceCure Medical Ltd.?

Eyal Shamir is the Chief Executive Officer of IceCure Medical Ltd.

Where is IceCure Medical Ltd. incorporated?

IceCure Medical Ltd. is incorporated in Israel.

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on March 27, 2025 by Eyal Shamir regarding IceCure Medical Ltd. (ICCM).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing